Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7210)
All Articles published online
|
Publishing Process of This Article
|
Jun 24, 2016 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Transplantation
ISSN
2220-3230
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lee SD, Lee B, Kim SH, Joo J, Kim SK, Kim YK, Park SJ. Proposal of new expanded selection criteria using total tumor size and 18F-fluorodeoxyglucose - positron emission tomography/computed tomography for living donor liver transplantation in patients with hepatocellular carcinoma: The National Cancer Center Korea criteria. World J Transplant 2016; 6(2): 411-422 [PMID: 27358787 DOI: 10.5500/wjt.v6.i2.411] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v6/i2/411.htm |
| Number | Citing Articles |
| 1 |
Parissa Tabrizian, Matthew L. Holzner, Neil Mehta, Karim Halazun, Vatche G. Agopian, Francis Yao, Ronald W. Busuttil, John Roberts, Jean C. Emond, Benjamin Samstein, Robert S. Brown, Marc Najjar, William C. Chapman, Majella Mb. Doyle, Sander S. Florman, Myron E. Schwartz, Josep M. Llovet. Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma. JAMA Surgery 2022; doi: 10.1001/jamasurg.2022.2800
|
| 2 |
Anju Mullath, Murali Krishna. Hepatocellular carcinoma – time to take the ticket. World Journal of Gastrointestinal Surgery 2019; 11(6): 287-295 doi: 10.4240/wjgs.v11.i6.287
|
| 3 |
Neil Mehta. Hepatocellular Carcinoma—How to Determine Therapeutic Options. Hepatology Communications 2020; 4(3): 342 doi: 10.1002/hep4.1481
|
| 4 |
2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Korean Journal of Radiology 2022; 23(12): 1126 doi: 10.3348/kjr.2022.0822
|
| 5 |
Dong-Hwan Jung, Shin Hwang, Gi-Won Song. Selection criteria of living donor liver transplantation for hepatocellular carcinoma developed in Korean transplant centers. Annals of Liver Transplantation 2021; 1(1): 29 doi: 10.52604/alt.21.0005
|
| 6 |
Neil Mehta, Prashant Bhangui, Francis Y. Yao, Vincenzo Mazzaferro, Christian Toso, Nobuhisa Akamatsu, Francois Durand, Jan Ijzermans, Wojciech Polak, Shusen Zheng, John P. Roberts, Gonzalo Sapisochin, Taizo Hibi, Nancy Man Kwan, Mark Ghobrial, Avi Soin. Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference. Transplantation 2020; 104(6): 1136 doi: 10.1097/TP.0000000000003174
|
| 7 |
Neil Mehta, Francis Y. Yao. Living donor liver transplantation for hepatocellular carcinoma: To expand (beyond Milan) or downstage (to Milan)?. Liver Transplantation 2018; 24(3): 327 doi: 10.1002/lt.25017
|
| 8 |
Onur Yaprak, Sencan Acar, Gokhan Ertugrul, Murat Dayangac. Role of pre-transplant 18F-FDG PET/CT in predicting hepatocellular carcinoma recurrence after liver transplantation. World Journal of Gastrointestinal Oncology 2018; 10(10): 336-343 doi: 10.4251/wjgo.v10.i10.336
|
| 9 |
Dong-Hwan Jung, Shin Hwang, Gi-Won Song. Selection criteria of living donor liver transplantation for hepatocellular carcinoma developed in Korean transplant centers. Annals of Liver Transplantation 2021; 1(1): 48 doi: 10.52604/alt.11.0007
|
| 10 |
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma. Journal of Liver Cancer 2023; 23(1): 1 doi: 10.17998/jlc.2022.11.07
|
| 11 |
Arno Kornberg, Martina Schernhammer, Helmut Friess. 18F-FDG-PET for Assessing Biological Viability and Prognosis in Liver Transplant Patients with Hepatocellular Carcinoma. Journal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2017.00014
|
| 12 |
Louis Leong-Liung Ling, Chien-Chin Hsu, Chee-Chien Yong, Ahmed M. Elsarawy, Yi-Chia Chan, Chih-Chi Wang, Wei-Feng Li, Ting-Lung Lin, Fang-Ying Kuo, Yu-Fan Cheng, Li-Man Lin, Chao-Long Chen, Chih-Che Lin. FDG-PET predicted unfavorable tumor histology in living donor liver transplant recipients; a retrospective cohort study. International Journal of Surgery 2019; 69: 124 doi: 10.1016/j.ijsu.2019.07.035
|
| 13 |
Marco Biolato, Tiziano Galasso, Giuseppe Marrone, Luca Miele, Antonio Grieco. Upper Limits of Downstaging for Hepatocellular Carcinoma in Liver Transplantation. Cancers 2021; 13(24): 6337 doi: 10.3390/cancers13246337
|
| 14 |
Dong-Sik Kim, Young-In Yoon, Beom Kyung Kim, Ashok Choudhury, Anand Kulkarni, Jun Yong Park, Jongman Kim, Dong Hyun Sinn, Dong Jin Joo, YoungRok Choi, Jeong-Hoon Lee, Ho Joong Choi, Ki Tae Yoon, Sun Young Yim, Cheon-Soo Park, Deok-Gie Kim, Hae Won Lee, Won-Mook Choi, Young Eun Chon, Woo-Hyoung Kang, Jinsoo Rhu, Jae Geun Lee, Yuri Cho, Pil Soo Sung, Han Ah Lee, Ji Hoon Kim, Si Hyun Bae, Jin Mo Yang, Kyung-Suk Suh, Mamun Al Mahtab, Soek Siam Tan, Zaigham Abbas, Ananta Shresta, Shahinul Alam, Anil Arora, Ashish Kumar, Pravin Rathi, Ruveena Bhavani, Charles Panackel, Kuei Chuan Lee, Jun Li, Ming-Lung Yu, Jacob George, Tawesak Tanwandee, Sen-Yung Hsieh, Chee Chien Yong, Mohamed Rela, H. C. Lin, Masao Omata, Shiv Kumar Sarin. Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation. Hepatology International 2024; 18(2): 299 doi: 10.1007/s12072-023-10629-3
|
| 15 |
Jan Lerut, Maxime Foguenne, Quirino Lai. Hepatocellular cancer selection systems and liver transplantation: from the tower of babel to an ideal comprehensive score. Updates in Surgery 2021; 73(5): 1599 doi: 10.1007/s13304-021-01078-4
|
| 16 |
Brandon A. Howard, Terence Z. Wong. 18F-FDG-PET/CT Imaging for Gastrointestinal Malignancies. Radiologic Clinics of North America 2021; 59(5): 737 doi: 10.1016/j.rcl.2021.06.001
|
| 17 |
Hae Won Lee, Kyung-Suk Suh. Advancements of liver transplantation for hepatocellular carcinoma in Korea. Japanese Journal of Clinical Oncology 2017; 47(2): 93 doi: 10.1093/jjco/hyw168
|
| 18 |
Young-In Yoon, Sung-Gyu Lee. Living Donor Liver Transplantation for Hepatocellular Carcinoma: An Asian Perspective. Digestive Diseases and Sciences 2019; 64(4): 993 doi: 10.1007/s10620-019-05551-4
|
| 19 |
Abu Bakar Hafeez Bhatti, Ammal Imran Qureshi, Rizmi Tahir, Faisal Saud Dar, Nusrat Yar Khan, Haseeb Haider Zia, Shahzad Riyaz, Atif Rana. When to call it off: defining transplant candidacy limits in liver donor liver transplantation for hepatocellular carcinoma. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07238-w
|
| 20 |
Neil Mehta, Jennifer L. Dodge, John P. Roberts, Ryutaro Hirose, Francis Y. Yao. Alpha‐Fetoprotein Decrease from > 1,000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes. Hepatology 2019; 69(3): 1193 doi: 10.1002/hep.30413
|
| 21 |
Hao Liu, Vrishketan Sethi, Xingjie Li, Yao Xiao, Abhinav Humar. Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future. Seminars in Liver Disease 2024; 44(01): 079 doi: 10.1055/a-2242-7543
|
| 22 |
Hae Moon, Ji Eun Choi, In Joon Lee, Tae Hyun Kim, Seong Hoon Kim, Young Hwan Ko, Hyun Boem Kim, Byung-Ho Nam, Joong-Won Park. All-treatment array of hepatocellular carcinoma from initial diagnosis to death: observation of cumulative treatments. Journal of Cancer Research and Clinical Oncology 2017; 143(11): 2327 doi: 10.1007/s00432-017-2480-9
|
| 23 |
Mignote Yilma, Neil Mehta. Optimal Liver Transplantation Criteria for Hepatocellular Carcinoma. Surgical Oncology Clinics of North America 2024; 33(1): 133 doi: 10.1016/j.soc.2023.06.011
|
| 24 |
Jae Hyun Yoon, Sung Kyu Choi. Management of early-stage hepatocellular carcinoma: challenges and strategies for optimal outcomes. Journal of Liver Cancer 2023; 23(2): 300 doi: 10.17998/jlc.2023.08.27
|
| 25 |
Elizabeth C. Verna, Yuval A. Patel, Avin Aggarwal, Archita P. Desai, Catherine Frenette, Anjana A. Pillai, Reena Salgia, Anil Seetharam, Pratima Sharma, Courtney Sherman, Georgios Tsoulfas, Francis Y. Yao. Liver transplantation for hepatocellular carcinoma: Management after the transplant. American Journal of Transplantation 2020; 20(2): 333 doi: 10.1111/ajt.15697
|
| 26 |
Varun Saxena, Neil Mehta. Current Transplant Criteria for Hepatocellular Carcinoma—Overuse or Underuse. Current Hepatology Reports 2020; 19(4): 470 doi: 10.1007/s11901-020-00555-5
|
| 27 |
Arno Kornberg, Helmut Friess. 18F-fludeoxyglucose positron emission tomography for diagnosis of HCC: implications for therapeutic strategy in curative and non-curative approaches. Therapeutic Advances in Gastroenterology 2019; 12: 175628481983620 doi: 10.1177/1756284819836205
|
| 28 |
Phillipe Abreu, Andre Gorgen, Christopher Griffiths, Tommy Ivanics, Gonzalo Sapisochin. Downstaging and Expanded Criteria Hepatocellular Carcinoma Liver Transplantation. Current Hepatology Reports 2019; 18(4): 400 doi: 10.1007/s11901-019-00492-y
|
| 29 |
Sungmin Kang, Joo Dong Kim, Dong Lak Choi, Byungwook Choi. Predicting the Recurrence of Hepatocellular Carcinoma after Primary Living Donor Liver Transplantation Using Metabolic Parameters Obtained from 18F-FDG PET/CT. Journal of Clinical Medicine 2022; 11(2): 354 doi: 10.3390/jcm11020354
|
| 30 |
Sang Mi Lee, Hong Soo Kim, Sangheun Lee, Jeong Won Lee. Emerging role of <sup>18</sup>F-fluorodeoxyglucose positron emission tomography for guiding management of hepatocellular carcinoma. World Journal of Gastroenterology 2019; 25(11): 1289-1306 doi: 10.3748/wjg.v25.i11.1289
|
| 31 |
Neil Mehta, R. Katie Kelley, Francis Y. Yao. Refining the approach to down-staging of HCC prior to liver transplantation: Patient selection, loco-regional treatments, and systemic therapies. Hepatology 2023; doi: 10.1097/HEP.0000000000000452
|
| 32 |
|
| 33 |
Saneya Pandrowala, Shraddha Patkar, Mahesh Goel, Darius Mirza, S. K. Mathur. Surgical resection for large hepatocellular carcinoma and those beyond BCLC: systematic review with proposed management algorithm. Langenbeck's Archives of Surgery 2023; 408(1) doi: 10.1007/s00423-023-02881-w
|
| 34 |
Neil Mehta, Francis Y. Yao. What Are the Optimal Liver Transplantation Criteria for Hepatocellular Carcinoma?. Clinical Liver Disease 2019; 13(1): 20 doi: 10.1002/cld.793
|
| 35 |
Abu Bakar Hafeez Bhatti, Wajih Naqvi, Nusrat Yar Khan, Haseeb Haider Zia, Faisal Saud Dar, Zahid Amin Khan, Atif Rana. Living donor liver transplantation for advanced hepatocellular carcinoma including macrovascular invasion. Journal of Cancer Research and Clinical Oncology 2022; 148(1): 245 doi: 10.1007/s00432-021-03665-9
|
| 36 |
Astrid Bauschke, Annelore Altendorf-Hofmann, Lukas Brückner, Robert Drescher, Martin Freesmeyer, Utz Settmacher. Impact of metabolic indices of 18F-fluorodeoxyglucose positron emission tomography/computed tomography on post transplantation recurrence of hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2023; 149(4): 1401 doi: 10.1007/s00432-022-04009-x
|
| 37 |
Kali Zhou, Neil Mehta. Downstaging to Liver Transplant. Clinics in Liver Disease 2020; 24(4): 665 doi: 10.1016/j.cld.2020.07.005
|
| 38 |
Ashley J.P. Limkemann, Phillipe Abreu, Gonzalo Sapisochin. How far can we go with hepatocellular carcinoma in living donor liver transplantation?. Current Opinion in Organ Transplantation 2019; 24(5): 644 doi: 10.1097/MOT.0000000000000692
|
| 39 |
Vijay Subramanian, William Chapman. Living Donor Liver Transplant for Hepatocellular Carcinoma. Annals of Surgical Oncology 2019; 26(6): 1594 doi: 10.1245/s10434-019-07250-w
|
| 40 |
Pedro Antonio Cascales-Campos, Pablo Ramírez Romero, Marcel André Schneider, Victor Lopez-Lopez, José Luis Navarro, Laura Frutos, Jose Antonio Pons Miñano, Pascual Parrilla Paricio. Positron emission tomography/computed tomography in patients with hepatocellular carcinoma undergoing liver transplantation. Useful, necessary or irrelevant?. European Journal of Radiology 2017; 91: 155 doi: 10.1016/j.ejrad.2017.03.013
|
| 41 |
Hsin-Rou Liang, Chia-En Hsieh, Kuo-Hua Lin, Chih-Jan Ko, Yu-Ju Hung, Ya-Lan Hsu, Yao-Li Chen. Living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria: outcome of expanded criteria in tumor size. BMC Surgery 2021; 21(1) doi: 10.1186/s12893-021-01403-z
|
| 42 |
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma. Clinical and Molecular Hepatology 2022; 28(4): 583 doi: 10.3350/cmh.2022.0294
|